Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study

AIMS: To investigate the feasibility of serum extra spindle pole bodies-like 1 (ESPL1) used as a biomarker for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). METHODS: 131 chronic HBV-infection patients were recruited and divided into HBV S gene integration, non-HBV S g...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rongming, Zang, Weiwei, Hu, Bobin, Deng, Deli, Ling, Xiaozhang, Zhou, Huikun, Su, Minghua, Jiang, Jianning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739072/
https://www.ncbi.nlm.nih.gov/pubmed/33308056
http://dx.doi.org/10.1177/1533033820980785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739072/
https://www.ncbi.nlm.nih.gov/pubmed/33308056
http://dx.doi.org/10.1177/1533033820980785

Ejemplares similares